PA
VYGR icon

Profund Advisors’s Voyager Therapeutics VYGR Stock Holding History

Profund Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,762
Closed -$133K – 1159
2024
Q2 		$133K Sell
16,762
-2,154
-11% -$18.1K ﹤0.01% 1027
2024
Q1 		$176K Buy
+18,916
New +$160K 0.01% 1092

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Profund Advisors's VYGR Position: Q3 2024 in Review

Profund Advisors sold out of Voyager Therapeutics (VYGR) in Q3 2024, closing a stake of 16,762 shares — an estimated $133K sold.

Profund Advisors first reported a position in VYGR in Q1 2024 and held it in 2 quarters. The position peaked at $176K in Q1 2024. 128 funds tracked by Wall St. Rank hold VYGR as of Q3 2024.

  • Profund Advisors reported no remaining Voyager Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Profund Advisors sold 16,762 Voyager Therapeutics shares in Q3 2024, an estimated $133K.
  • Profund Advisors first reported a position in Voyager Therapeutics in Q1 2024 and held it in 2 quarters.
  • Profund Advisors's Voyager Therapeutics position peaked at $176K in Q1 2024.
  • 128 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2024.

Based on Profund Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.